Overview: SS-A Ro Antibody TestIntroduction: The SS-A Ro Antibody Test detects SS-A/Ro antibodies to diagnose Sjögren's syndrome or lupus, causing dry eyes. Aligned with 2023 ACR guidelines, it uses immunoassays for high specificity, supporting autoimmune screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in immunology for patients with suspected Sjögren's syndrome or lupus.
Other Names: SS-A/Ro Antibody Assay, Anti-Ro Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: SS-A/Ro testing began in the 1960s with autoimmune research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects SS-A/Ro antibodies to diagnose Sjögren's syndrome or lupus, guides treatment, and evaluates patients with dry eyes.
Test Parameters: 1. SS-A/Ro Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of dry eyes, joint pain, or autoimmune symptoms.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document dry eyes, joint pain, or family history of Sjögren's syndrome/lupus. Include current medications, especially immunosuppressants.
Consent: Written consent required, detailing the tests purpose, autoimmune disease implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) to detect SS-A/Ro antibodies. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for autoimmune diagnosis.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. Cross-reactivity with other autoantibodies may reduce specificity.
Clinical Significance: Positive SS-A/Ro antibodies confirm Sjögren's syndrome or lupus, guiding immunosuppressive therapy. Negative results may require SS-B/La testing.
Specialist Consultation: Consult a rheumatologist for result interpretation and treatment planning.
Additional Supporting Tests: SS-B/La, ANA, or salivary gland biopsy to confirm Sjögren's syndrome/lupus diagnosis.
Test Limitations: Non-specific for certain autoimmune conditions; clinical correlation is needed. Sample quality affects sensitivity.
References: ACR Sjögren's Guidelines, 2023; Arthritis & Rheumatology, Ramos-Casals M, 2022.
